COVID-19肺炎与肺中和肺胸相关:流行病学和演变
Rim Khemakhem1, Issraa Wadhane1, Wided Dhouib2
1Department of Pneumology, HEDI CHAKER Hospital, University of Sfax, Sfax, Tunisia.
Tanaffos
|July 24, 2025
概括
肺中和肺胸是罕见的COVID-19并发症. 这些疾病,尤其是自发性疾病,与死亡率的增加有关,这凸显了对风险因素和管理策略的进一步研究的需要.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
背景情况:
- 肺中症 (PM) 和肺胸部 (PTX) 是在COVID-19肺炎患者中观察到的不常见并发症.
- 在COVID-19中,PM和PTX的确切病理生理机制尚不完全理解.
研究的目的:
- 在住院COVID-19患者中调查肺中和肺胸病的发生,管理和结果.
- 确定患有PM或PTX的COVID-19患者的潜在风险因素和死亡率的关联.
主要方法:
- 一项从2021年3月至7月进行的回顾性研究.
- 纳入标准:被诊断为COVID-19的住院患者,他们患有PM或PTX.
- 数据分析的重点是患病率,管理策略以及与死亡率和临床参数的相关性.
主要成果:
- 分析了33名患有PM或PTX的COVID-19患者.
- 颗粒素的发病率为1.2% (自发性) 和1.71% (催产性).
- 死亡率与PM发生,患者年龄,放射性严重程度,呼吸道感染严重程度,压缩征兆和机械通风使用显著相关.
结论:
- 经历PM-PTX的COVID-19患者的死亡率可能更高.
- 进一步的研究对于阐明风险因素和建立COVID-19中PM-PTX的标准化管理协议至关重要.
相关概念视频
01:30Pneumonia I: Introduction
331
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
331
01:29Pneumonia II: Pathophysiology
565
The pathophysiology of pneumonia involves the following steps:
565
01:26Pneumothorax-I
345
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
345
01:30Pneumonia III: Complications and Assessment
442
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
442
01:27Pneumothorax-II
366
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
366
01:28Pneumonia IV: Management
451
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
451